Order Code RL33485
CRS Report for Congress
Received through the CRS Web
U.S. International HIV/AIDS, Tuberculosis, and
Malaria Spending: FY2004-FY2007
June 19, 2006
Tiaji Salaam-Blyther
Specialist in Foreign Affairs
Foreign Affairs, Defense, and Trade Division
Congressional Research Service ˜ The Library of Congress

---

U.S. International HIV/AIDS, Tuberculosis, and Malaria
Spending: FY2004-FY2007
Summary
On January 28, 2003, during his State of the Union Address, President George
Bush proposed that the United States spend $15 billion over five years to combat
HIV/AIDS through the President’s Emergency Plan for AIDS Relief (PEPFAR). The
initiative focuses on 15 countries in Africa, Asia, Latin America, and the Caribbean.
The plan anticipated spending $10 billion of the $15 billion on the 15 focus
countries, $4 billion on 108 non-focus countries and international HIV/AIDS
research, and $1 billion on contributions to the Global Fund to Fight AIDS,
Tuberculosis, and Malaria. Between FY2004 and FY2008, the initiative was to
support care for 10 million people living with AIDS, including children orphaned by
AIDS; prevent 7 million new HIV infections; and support efforts to provide anti-
retroviral medication (ARV) to 2 million HIV-infected people.
Between FY2004 and FY2006 Congress allocated $8.6 billion to fighting the
global spread of HIV/AIDS, TB, and malaria, of which $3.4 billion was provided in
FY2006 appropriations. The largest portion of PEPFAR funds is provided through
annual foreign operations appropriations, which in FY2006 directed about $2.8
billion to fighting the three diseases. The $545 million directed to the Global Fund
in FY2006 appropriations reflected the largest U.S. contribution to date, with $446
million provided through Foreign Operations Appropriations and $99 million through
Labor/HHS/Education Appropriations. Final conference funding levels for FY2006
AIDS, TB, and malaria initiatives were $286 million more than the Administration
request, $230 million more than the House suggested, and nearly $121 million less
than the Senate proposed.
For FY2007, the President requests about $4.3 billion for global HIV/AIDS, TB,
and malaria efforts, $3.665 billion of which would be funded through foreign
operations appropriations. If Congress fully funds the President’s request, the United
States will have spent $12.8 billion on fighting the three diseases between FY2004
and FY2007. The House Foreign Operations Appropriations bill (H.R. 5522)
proposes spending about $3.62 billion (some $40 million less) on the three diseases
than the Administration requests for FY2007. This represents a significant departure
from congressional funding trends since the inception of PEPFAR, as Congress has
historically surpassed the Administration’s requests during this period. The Senate
Foreign Operations subcommittee has not yet reported its spending proposal. This
report will review U.S. spending on the three diseases between FY2004 and FY2007,
and will be updated to include congressional actions.

---

Contents
Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Explanation of Data in Table 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Initiatives Funded through Foreign Operations Appropriations . . . . . . . . . . 4
U.S. Contributions to International AIDS Initiatives . . . . . . . . . . . . . . . 5
Initiatives Funded through Labor/HHS Appropriations . . . . . . . . . . . . . . . . 5
Initiatives Funded through Other Appropriations . . . . . . . . . . . . . . . . . . . . . 6
Department of Defense HIV/AIDS Prevention Education . . . . . . . . . . 6
Section 416(b) Food Aid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Prevention of Mother and Child HIV Transmission Initiative . . . . . . . 6
Global Fund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Explanation of Data Discrepancies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
CRS Data versus Figures Reported in the Press . . . . . . . . . . . . . . . . . . . . . . 7
CRS Data Versus OGAC Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
List of Tables
Table 1. U.S. Global HIV/AIDS, TB, and Malaria Funding . . . . . . . . . . . . . . . . 3
Table 2. Funding for U.S. Contributions to the Global Fund . . . . . . . . . . . . . . . . 7
Table 3. Comparison of CRS and OGAC Data Presentation . . . . . . . . . . . . . . . . 8

---

U.S. International HIV/AIDS. Tuberculosis,
and Malaria Spending: FY2004-FY2007
Background
The President proposed on January 28, 2003, during his State of the Union
Address, that the United States spend $15 billion over five fiscal years to combat
HIV/AIDS, tuberculosis (TB), and malaria through the President’s Emergency Plan
for AIDS Relief (PEPFAR). The United States Leadership Against HIV/AIDS,
Tuberculosis, and Malaria Act of 2003 (P.L. 108-25) established the office of the
Global HIV/AIDS Coordinator (OGAC) at the U.S. Department of State, and made
the Coordinator responsible for administering all global HIV/AIDS funds. The
initiative intends to spend $10 billion of the funds in 15 countries,1 direct $4 billion
to 108 additional non-focus countries and to international HIV/AIDS research, and
donate $1 billion of the $15 billion to the Global Fund. Between FY2004 and
FY2008, the initiative aims to support care for 10 million people living with AIDS,
including children orphaned by AIDS; prevent 7 million new HIV infections; and
support efforts to provide anti-retroviral medication (ARV) to 2 million HIV-infected
people.2
Between FY2004 and FY2006 Congress allocated $8.6 billion to fighting the
global spread of HIV/AIDS, TB, and malaria, of which $3.4 billion was provided in
FY2006 appropriations. Most funding for international HIV/AIDS, TB, and malaria
programs is included in annual appropriations for Foreign Operations and for the
Departments of Health and Human Services, Labor, and Education (Labor/HHS).
Table 1 summarizes funding for such programs through these and other
appropriations.3 Amounts reported in Table 1 for FY2004 through FY2006 have
been adjusted for the rescissions imposed in those years.
In June 2005, President Bush announced the President’s Malaria Initiative
(PMI), a plan to increase funding of malaria prevention by more than $1.2 billion
1 The 15 focus countries are: Botswana, Cote d’Ivoire, Ethiopia, Guyana, Haiti, Kenya,
Mozambique, Namibia, Nigeria, Rwanda, South Africa, Tanzania, Uganda, Vietnam, and
Zambia.
2 White House Fact Sheet, “The President’s Emergency Plan for AIDS Relief.” January 29,
2003. [http://www.state.gov/p/af/rls/fs/17033.htm]
3 For earlier years, see CRS Report RS21114, HIV/AIDS: Appropriations for Worldwide
Programs in FY2001 and FY2002, by Raymond W. Copson; and Kaiser Family Foundation,
Policy Brief: U.S. Government Funding for Global HIV/AIDS Through FY2005, prepared
by Jennifer Kates and Todd Summers. [http://www.kff.org/hivaids/7110.cfm]

---

CRS-2
between FY2006 and FY2010 in 15 countries. In FY2006, appropriators provided
$103 million for U.S. bilateral malaria programs.4 The FY2007 request of $225
million for malaria represents an increase in bilateral spending on malaria, as PMI
enters its second year of implementation. The Administration anticipates increasing
the number of focus countries from three to seven in FY2007. H.R. 5522, the
FY2007 House Foreign Operation Appropriations bill, allocates a total of $179
million to bilateral malaria efforts, of which $177.59 million is funded through
USAID Child Survival and Health Account (CSH) and an additional $1.45 million
from Other Accounts.5 Budget analysts point out that the difference between FY2007
House and Administration proposed PEPFAR spending levels is largely comprised
of differences in bilateral malaria allocations.
Since USAID will lead PMI, OGAC will no longer oversee implementation of
bilateral malaria initiatives. Consequently, after FY2005, OGAC will no longer
include malaria spending in progress reports on PEPFAR. However, for
comparability and because malaria has been included in PEPFAR spending since
FY2004, figures in this report include malaria spending in PEPFAR totals for
FY2006 and FY2007. Without malaria funding, the FY2006 total for global
HIV/AIDS and TB would be approximately $3.3 billion, the FY2007 request would
be about $4.0 billion, and the House Foreign Operations recommendation would be
$3.4 billion.
4 Appropriators expected an additional $139.5 million would be spent on the disease through
the U.S. Global Fund contribution. When combined with bilateral malaria spending,
appropriates estimated that $242.5 million was spent on fighting the disease in FY2006.
5 Appropriators estimate that an additional $63.83 million would be spent on malaria
through U.S. Global Fund contributions. When combined with bilateral spending, the
House estimates that $242.9 million would be spent on global malaria initiatives through
FY2007 foreign operations appropriations.

---

CRS-3
Table 1. U.S. Global HIV/AIDS, TB, and Malaria Funding
($ millions)
FY2006
FY2007
Program
FY2004 FY2005
Actual Actual Request Estimate Request House
1. Child Survival Assistance for HIV/AIDS
513.4
347.2
330.0
346.5
325.0 346.6
(excluding Global Fund)
2. Child Survival Assistance for TB & Malaria
155.0
168.6
109.0
178.2
304.0 267.6
3. Child Survival Assistance for Global Fund
397.6
248.0
100.0
247.5
100.0 200.0
4. FY2004 Global Fund Carryover
-87.8
87.8
n/a
n/a
n/a
n/a
5. Other Accounts for HIV/AIDS, TB &
Malariaa
51.7
51.1
53.0
42.6
40.4
33.9
6. State Department GHAI
488.1 1,373.9
1,870.0
1,775.1
2,794.0 2,528.0
7. GHAI for the Global Fund
0.0
0.0
100.0
198.0
100.0 244.5
8. Foreign Military Financing
1.5
2.0
2.0
1.9
1.6
0.0
9. Subtotal, Foreign Operations
1,519.5 2,278.6
2,564.0
2,789.8
3,665.0 3,620.6
Appropriations
10. CDC Global AIDS Program
273.9
123.8b
123.9
122.7
121.9
11. CDC International Applied HIV Prevention
Research c,d
11.0
11.0
11.0
10.9
0.0
12. CDC international TB and malaria d
17.9
15.9
11.0
10.9
11.0
13. NIH International Research c,d
317.2
332.3
350.0
346.5
368.0
14. Global Fund contribution NIH
149.1
99.2
100.0
99.0
100.0
15. DOL AIDS in the Workplace Initiative
9.9
2.0
—
—
0.0
16. Subtotal, Labor/HHS Appropriations
779.0
584.2
595.9
590
600.9
17. DOD HIV/AIDS prevention education,
4.2
7.5
—
5.2
0.0
primarily in Africa
18. Section 416(b) Food Aid
24.8
24.8
—
24.8
10.0
19. TOTAL
2,327.5 2,895.1
3159.9
3,409.8
4,275.9
Sources: Prepared by CRS from appropriations legislation figures and interviews with Administration staff.
a. For description of “Other Accounts,” see discussion on Line 5 under “Explanation of Data in Table 1,” below.
b. According to CDC, this apparent decrease compared to the previous year reflected a change in budget structure that
removed overhead and indirect costs from the program. Moreover, mother and child prevention funds were shifted
to the Global HIV/AIDS Initiative. The change in budget structure also affected the FY2006 request. See section
on Labor/HHS appropriations.
c. Not earmarked, although funds could be provided at the Administration’s discretion.
d. Estimated amounts.

---

CRS-4
Explanation of Data in Table 1
Initiatives Funded through Foreign Operations
Appropriations
Line 1 in Table 1 refers to USAID bilateral HIV/AIDS programs funded
through Child Survival and Health Programs Fund (CSH). Since FY2005, all U.S.
AIDS funding in the focus countries has been under the direction of the Global AIDS
Coordinator at the Department of State, except for a small amount still coming
through HHS programs. Congressional appropriators first made this shift in the
FY2005 appropriations in order “to simplify budget processes and improve
transparency.” (H.Rept. 108-599; see also the conference report, H.Rept. 108-792.)
Line 2 refers to USAID bilateral TB and malaria programs, which are funded
through CSH and “other accounts” (see discussion on Line 5) in the appropriations
legislation. The FY2007 House-passed Foreign Operations Appropriations bill (H.R.
5522), per the Administration’s request, does not include malaria funding through
PEPFAR. However, for comparability, this report has included malaria funds in the
above chart. H.R. 5522 allocates $179.0 million on USAID bilateral malaria
programs, of which $177.6 million would be funded through the Child Survival and
Health Account (CSH), and an additional $1.4 million would be provided from other
accounts.6 Similarly, H.R. 5522 directs $101.55 to global TB programs, of which $90
million would be spent through CSH and an additional $11.55 million through other
accounts.7
Line 3 encompasses U.S. Global Fund contributions from CSH. In FY2004, as
shown in Line 4, $87.8 million of the amount appropriated to the Global Fund was
not provided per legislative provisions limiting U.S. Global Fund contributions to
33% of the amount contributed by all donors.8 The FY2005 Consolidated
Appropriations legislation directed that these withheld funds be provided to the
Global Fund in FY2005, subject, like the remainder of the U.S. contribution, to the
33% proviso.
6 The House estimates that $63.8 million would be spent on malaria through U.S. Global
Fund contributions. When added to U.S. bilateral initiatives, the House suggests that a total
of $242.9 million be spent on global malaria initiatives.
7 The House estimates that an additional $89.39 million would be spent on tuberculosis
through U.S. Global Fund contributions, totaling $180.94 for global TB efforts when
combined with bilateral TB funding.
8 These provisions are found in Sec. 202 of P.L. 108-25, the United States Leadership
against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, as amended by P.L. 108-199,
the FY2004 Consolidated Appropriations. See CRS Report RL33396, The Global Fund to
Fight AIDS, Tuberculosis, and Malaria: Progress Report and Issues for Congress, by Tiaji
Salaam-Blyther, for more information.

---

CRS-5
Line 5 in Table 1 indicates that other bilateral assistance is used to combat
AIDS, tuberculosis, and malaria. This assistance includes food aid,9 Economic
Support Fund aid (ESF), assistance for the former Soviet Union under the Freedom
Support Act (FSA), and Assistance for Eastern Europe and the Baltics (SEED).
The State Department’s Global HIV/AIDS Initiative (GHAI), referred to in Line
6 of Table 1, is the major component of the President’s Emergency Plan for AIDS
Relief (PEPFAR), announced by President Bush on January 28, 2003. In FY2007,
the House proposes that the GHAI Global Fund contribution be taken from GHAI
bilateral program funds.
Line 8 of Table 1 refers to Foreign Military Financing (FMF) for equipment
purchases to support a Military Health Affairs program under the Department of
Defense (DOD), offering HIV/AIDS prevention education, primarily to African
armed forces. The program itself is referred to in Line 17. Line 9 provides a subtotal
for HIV/AIDS, TB, and malaria programs funded through the Foreign Operations
Appropriations.
U.S. Contributions to International AIDS Initiatives. Although not
specified in Table 1, Line 9 includes U.S. contributions to international AIDS efforts,
such as international microbicide research, the International AIDS Vaccine Initiative
(IAVI), and the United Nations Joint Program on HIV/AIDS (UNAIDS). The
FY2005 Consolidated Appropriations bill set aside $30 million in CSH funding for
the development of microbicides, up from $22 million in FY2004. The measure also
provided $27 million from CSH for IAVI, compared with $26 million in FY2004.
The bill specified that $27 million should be contributed to UNAIDS from GHAI,
while the amount specified for FY2004 was $26 million. For FY2006, appropriators
directed $40 million to microbicides, $27 million to IAVI, and $30 million to
UNAIDS. The House proposes that $45 million be spent on microbicides, about $29
million be directed to IAVI, and $27 million be allocated to a U.S. UNAIDS
contributions in FY2007. Additionally, the House urges the Global AIDS
Coordinator to provide additional funds for microbicides research through PEPFAR.
Initiatives Funded through Labor/HHS Appropriations
Lines 10 through Lines 16 in Table 1 refer to global AIDS programs funded
through the Labor/HHS Appropriations. The Centers for Disease Control and
Prevention (CDC) at HHS administers the Global AIDS Program (GAP), which
promotes prevention, care, and capacity building in AIDS-stricken countries.
Funding for GAP appeared to drop in FY2005, as compared to FY2004, in part
because CDC adopted a new budget structure that removed overhead and indirect
costs from the request, which now solely reflects spending on the program itself.
Moreover, funding for mother-to-child transmission prevention programs was
shifted to the Global HIV/AIDS Initiative at the Department of State (see below).
9 Such aid is in addition to the Section 416(b) food aid listed in Table 1. For a description
of food aid programs, see CRS Issue Brief IB98006, Agricultural Export and Food Aid
Programs, by Charles E. Hanrahan.

---

CRS-6
In addition to GAP, the CDC conducts AIDS prevention research overseas,
referred to in Line 11, which is part of the U.S. response to the global pandemic. Line
12 refers to CDC research on international TB and malaria. According to CDC, the
apparent decrease in this program under the FY2006 request reflects the change in
the HHS budget structure noted above. Meanwhile, as indicated in Line 13, the
National Institutes of Health (NIH) also conducts research with an international
dimension, focusing primarily on the development of a vaccine for international
markets. Appropriations for the CDC and NIH research programs are not specifically
earmarked in legislation. Line 14 refers to contributions to the Global Fund
channeled through NIH (see Table 2). As in previous years, the FY2007
Administration request does not include funding for the Global AIDS in the
Workplace Initiative implemented by the Department of Labor (Line 15).
Initiatives Funded through Other Appropriations
Department of Defense HIV/AIDS Prevention Education. Line 17 in
Table 1 refers to the Defense Department’s AIDS prevention education program. As
in previous years, funding for the program was not requested in the FY2006 or
FY2007 Department of Defense appropriations. However, Congress provided $5.3
million for the program in FY2006.
Section 416(b) Food Aid. Since FY2002, Congress has directed that $25
million of any aid provided through the Section 416(b) food aid program, which
provides for the donation of surplus food commodities, be used to mitigate the effects
of HIV/AIDS overseas (Line 18). In subsequent years, this assistance was not
requested by the Administration, but Congress continued to make provisions for it
in Department of Agriculture appropriations.
Prevention of Mother and Child HIV Transmission Initiative. The
President’s International Mother and Child HIV Prevention Initiative was announced
on June 19, 2002. This initiative, under Administration plans, was to total $500
million, with $200 million requested in FY2003 and $300 million requested in
FY2004, to be provided in equal amounts from the Foreign Operations
Appropriations and the Labor/HHS appropriations for CDC international AIDS
programs. The FY2003 Omnibus Appropriations (P.L. 108-10) provided the $100
million requested through Foreign Operations in FY2003, but $40 million, rather
than $100 million, was provided through the CDC (H.Rept. 108-10). The
Consolidated Appropriations for FY2004 fully funded the request. It provided up to
$150 million under Foreign Operations and $150 million through the CDC. Under
the FY2005 request, funding for mother and child transmission programs were
provided through GHAI at the Department of State.
Global Fund
Although the United States has consistently provided about one-third of all
Global Fund contributions per fiscal year, Congress has placed restrictions on U.S.
contributions for various reasons. In FY2006, due to concerns about spending
practices, Congress requires that 20% of Global Fund contributions be withheld until
the Secretary of State certifies to the Appropriations Committees that the Fund has

---

CRS-7
undertaken a number of steps to strengthen oversight and spending practices
(P.L.109-102).10 The act allows the Secretary to waive the requirement if she
determines that a waiver is important to the national interest of the United States.
The House, in H.R. 5522, proposes that the 20% requirement be extended into
FY2007. However, the FY2007 legislation proposes that 25% of the funds be
withheld pending the Secretary of State’s certification, as opposed to 20% required
through FY2006 appropriations. The FY2007 House Foreign Operations
Appropriations bill also prohibits U.S. funds from being used to assist countries in
writing grant proposals.
Table 2 summarizes funding for U.S. Global Fund contributions, totaling more
than $2 billion ($2.066 billion) through FY2006. For more information on the
Global Fund, see CRS Report RL33396, The Global Fund to Fight AIDS,
Tuberculosis, and Malaria: Progress Report and Issues for Congress, by Tiaji
Salaam-Blyther.
Table 2. Funding for U.S. Contributions to the Global Fund
($ millions)
FY2006
FY2007
FY2001 FY2002 FY2003 FY2004 FY2005
Actual Actual Actual
Actual
Actual Request Enacted Request House
1. Foreign Operations
100
50.0
248.4
397.6
248.0
200.0
445.5
200.0
444.5
2. Labor/HHS
125.0
99.3
149.1
99.2
100.0
99.0
100.0
3. FY2004 Carryover
n/a
n/a
n/a
-87.8
87.8
n/a
n/a
n/a
n/a
TOTAL
100
175
347.7
458.9
435.0
300.0
544.5
300.0
Source: Compiled by CRS from appropriations legislation.
Explanation of Data Discrepancies
CRS Data versus Figures Reported in the Press
The press typically reported that the FY2004 Consolidated Appropriations
included $2.4 billion for international HIV/AIDS programs, rather than the $2.3
billion reported in Table 1. However, the $2.4 billion figure was the pre-rescission
amount for fighting HIV/AIDS, tuberculosis, and malaria. Moreover, as noted
above, $87.8 million appropriated for the Global Fund was not provided. Finally,
some amounts, such as NIH international research, were adjusted downward as final
spending information for the year became available.
10 The required steps are to (1) establish clear progress indicators upon which to determine
the release of incremental disbursements; (2) release such incremental disbursements only
if progress is being made based on those indicators; and (3) provide support and oversight
to country-level entities, such as country coordinating mechanisms, principal recipients, and
local Fund agents.

---

CRS-8
The amount provided for U.S. global HIV/AIDS programs under the FY2005
Consolidated Appropriations was typically reported as $2.9 billion, an amount that
included the $87.8 million carried over from FY2004. According to the conference
report on the FY2005 Consolidated Appropriations (H.Rept. 108-792), the amount
provided for fighting AIDS alone, rather than the three diseases, was $1.96 billion
in the Foreign Operations portion of the bill. This reflected an assumption that the
Global Fund was providing about 56% of its funds to fight HIV/AIDS. Using the
same assumption, the AIDS-only amount in the rest of the appropriations legislation
was approximately $580 million, making the AIDS-only total $2.5 billion.
CRS Data Versus OGAC Figures
The Office of the Global AIDS Coordinator (OGAC) released its Second
Annual Report to Congress, Action Today, A Foundation for Tomorrow: The
President’s Emergency Plan for AIDS Relief on February 8, 2006. The report
outlined, among other things, PEPFAR HIV/AIDS allocations per agency. Key data
differences are outlined below in Table 3.
Table 3. Comparison of CRS and OGAC Data Presentation
CRS
OGAC
CRS
OGAC
PROGRAM
FY2004 FY2004 FY2005 FY2005
1. Child Survival Assistance for HIV/AIDS
513.4
513.0
347.2
347.0
(excluding Global Fund)
2. Child Survival Assistance for TB & Malaria
155.0
155.0
168.6
168.0
3. Child Survival Assistance for Global Fund
397.6
398.0
248.0
248.0
4. FY2004 Global Fund Carryover
-87.8
0.0
87.8
0.0
5. Other bilateral assistance
51.7
52.0
51.1
52.0
6. State Department Global HIV/AIDS Initiative
488.1
488.0 1,373.9 1,374.0
(GHAI)
7. GHAI for the Global Fund
0.0
0.0
0.0
0.0
8. Foreign Military Financing
1.5
1.0
2.0
2.0
9. Subtotal, Foreign Operations Appropriations
1,519.5 1607.0 2,278.6 2191.0
10. CDC Global AIDS Program
273.9
274.0
123.8
124.0
11. CDC International Applied HIV Prevention
11.0
9.0
11.0
14.0
Research
12. CDC international TB and malaria
17.9
11.0
15.9
11.0
13. NIH International Research
317.2
317.0
332.3
332.0
14. Global Fund contribution NIH
149.1
149.0
99.2
99.0
15. DOL AIDS in the Workplace Initiative
9.9
10.0
2.0
2.0
16. Subtotal, Labor/HHS Appropriations
779.0
770.0
584.2
582.0
17. DOD HIV/AIDS prevention education
4.2
4.0
7.5
7.0
18. Section 416(b) Food Aid
24.8
0.0
24.8
0.0
19. TOTAL
2,327.5 2381.0 2,895.1 2780.0
Source: Compiled by CRS from appropriations legislation and OGAC Report to Congress.

---

CRS-9
Most of the differences between CRS and OGAC data can be attributed to
rounding. CRS provided exact figures while OGAC rounded its numbers. However,
some of the divergence can be attributed to other issues. Specifically, as shown in
Line 4, OGAC did not consider the 33% Global Fund contribution limitation when
reporting final U.S. Global Fund contribution. Consequently, funds deducted and
added in FY2004 and FY2005 were not included in OGAC-reported HIV/AIDS
spending totals.
Additionally, OGAC extracted CDC prevention of mother to child HIV
transmission (PMTCT) funds from CDC Global AIDS Program (GAP) funds, this
report did not. Consequently, in Appendix I of the OGAC report, the CDC GAP
allocation appears smaller ($125 million). This distinction is not reflected in Line 10
of Table 3, because this report combined the OGAC estimates of GAP and PMTCT
spending for comparability. CRS and OGAC data were the same for the two efforts
save rounding differences.
Data differences in Lines 10 and 11 are due to budgetary adjustments made after
OGAC published its final report. Additionally, OGAC reports that after FY2006, it
will discontinue including CDC international applied HIV prevention research and
international TB and malaria spending in its total.
OGAC did not include food assistance provided by the Department of
Agriculture to countries severely affected by HIV/AIDS in its HIV/AIDS spending
total, as seen in Line 18.
Additionally, since the launching of the President’s Malaria Initiative (PMI) in
FY2006, OGAC stopped including malaria funding in the overall PEPFAR total.
However, because PEPFAR sought to address three diseases, HIV/AIDS,
tuberculosis, and malaria funding have traditionally been grouped together since
FY2004. For comparability purposes CRS includes malaria spending in PEPFAR
totals for FY2006 and FY2007. However, in its report to Congress, OGAC provided
two totals for PEPFAR spending; one that includes malaria spending and one that
excludes it.

---